Tresiba? is contraindicated during episodes of hypoglycemia and in patients with hypersensitivity to Tresiba? or one of its excipients.
Tresiba? (insulin degludec injection) is indicated to improve glycemic control in patients 1 year of age and older with diabetes mellitus.